Advanced Tablet-Coating Technologies Aid Manufacturing Efficiency - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Advanced Tablet-Coating Technologies Aid Manufacturing Efficiency
New coating technologies achieve high uniformity and reduce waste through mixing system advances and pan and airflow configuration.


Pharmaceutical Technology
Volume 36, Issue 6, pp. 44-46

As the pharmaceutical market continues to grow, tablet manufacturers face countless operational decisions that impact their ability to compete. Processing efficiency is one of the most important issues, affecting time-to-market, budgets, and product margins.

Advanced tablet-coating technologies increase manufacturing efficiency and help manufacturers produce more tablets in less time by improving coating uniformity, reducing coating solution waste, and minimizing cleaning and maintenance.

Improved uniformity


Figure 1: Patented, high-efficiency coating drum (L.B. Bohle).
The biggest limitation of traditional tablet coaters is the amount of time and solution required to achieve uniformity. Typically, for a cosmetic coating (i.e., instant-release coating) using a conventional coater, tablet weight must increase 4–5% to achieve a uniform coat. The newest drum coaters, however, achieve the same coverage with only a 1.5–2% weight gain, primarily due to an advanced mixing system and pan configuration.


Figure 2: (a) Unmixed tablets are (b) fully mixed after 10 min. in a high-efficiency coater (Bohle Tablet Coater, L.B. Bohle).
This improved uniformity and mixing effect results in better distribution of the coating solution on the tablet surface. Thus, with a lower weight gain, manufacturers are able to achieve the color specification required.

Mixing system


Table 1: Percentages of each tablet color in the front, middle, and back of the coating pan demonstrate complete mixing after 10 min.
The mixing system of a high-efficiency coater uses patented spiral baffles to move tablets constantly, as shown in Figure 1. One of the baffles moves tablets to the back of the pan while the other brings them forward. In 10 min or less, manufacturers can attain tablet homogeneity in each batch as was demonstrated in a mixing experiment with white, red, and green tablets (see Figure 2). In this experiment, an approximate 500 mL sample was taken from the front, middle, and back of the mixer after 2, 5, and 10 min, and the percentage of white, red, and green tablets in each location was calculated. As shown in Table I, the tablets in the middle were almost perfectly mixed after 2 min, and all zones were completely mixed after 10 min.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here